Poly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis
Francesco Schettini(Target (United States)), Daniele Generali(University of Trieste), Pasquale Rescigno(Institute of Cancer Research), Ottavia Bernocchi(University of Trieste), Fabiola Giudici(University of Padua), Giovanni Scambia(Agostino Gemelli University Polyclinic), Ida Paris(Agostino Gemelli University Polyclinic), Mario Giuliano(Regione Campania), Marianna Sirico(Istituti Ospitalieri di Cremona), Silvia Paola Corona(Hôpital Cardiologique du Haut-Lévêque), Sabino De Placido, Mariavittoria Locci, Aleix Prat(Hospital Clínic de Barcelona), Giuseppe Curigliano(European Institute of Oncology)
Cited by 65
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k